Symmetry Medical Inc: (NYSE: SMA)

$7.73

-0.24 (-3.01%)

Volume 318,841

Jun 19 04:02 PM ET

Zacks Rank: 4-Sell

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		7.70 - 7.99
	
		52wk Low - High
		7.44 - 12.83
	
		Previous Close
		7.97
	
		Avg. Volume
		424,388
	
		Industry
		MED PRODUCTS
	
		Market Cap
		297.09 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.09
	
		P/E (F1)
		21.54
	
		Current Year Est.
		0.37
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		4
Sell

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		184 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/6/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            21.54
                        
                            PEG Ratio
                            2.39
                        
                            Current Year Est.
                            0.37
                        
                            Current Quarter Estimate
                            0.05
                        
                            Most Accurate Estimate
                            0.05
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-08-2013
                        
                            EPS Last Year
                            0.47
                        
                            Expected Earnings Growth
                            9.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Symmetry Medical products and services extend into medical device markets, such as orthopedic, spinal, trauma, dental, cardiovascular, ophthalmology, etc. They offer trusted brands Jet, Othy, PolyVac, Thornton and UltreXX.   
Full SMA Company Report

 Analyst Report on SMA

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
SMA Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.05	0.19	0.37	0.90
Number of Estimates	1	3	1	2
Low Estimate	0.04	0.18	0.32	0.87
High Estimate	0.06	0.21	0.42	NA
Year Ago EPS	0.12	0.16	0.50	0.37
EPS Growth	-58.33%	20.83%	-26.00%	143.24%

More SMA Estimates

Average Earnings Estimates for SMA

EPS Growth for SMA

Industry Analysis

Name	Symbol	Previous Close
SYMMETRY MEDICL	SMA	7.97
HAEMONETICS CP	HAE	42.71
ATRICURE INC	ATRC	9.12
BAXANO SURGICAL	BAXS	2.28
CARDICA INC	CRDC	1.19
ESSILOR INTL SA	ESLOY	55.99
INVIVO THERAPT	NVIV	3.89
PURE BIOSCIENCE	PURE	0.41
SHANDONG WEIGAO	SHWGF	1.29
ABAXIS INC	ABAX	46.89

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Symmetry Provides Dismal 2013 View

Jun 11, 2013

Symmetry 1Q Earnings Disappoint

May 03, 2013

Symmetry Reiterated at Neutral

Apr 05, 2013

Symmetry Launches New FlashPak

Mar 11, 2013

Symmetry Boosts Bookwalter Line

Mar 08, 2013

Symmetry Teams with UK Distributor

Feb 28, 2013

Symmetry Misses but Up Y-Y

Feb 22, 2013

Symmetry Surgical Expands in Mexico

Dec 03, 2012

More SMA Zacks Commentary

Financials

EPS TTM	0.47
Sales	411
Net Income	8
Price/Earnings	16.96
Price/Book	0.95
Price/Cash Flow	6.50
Price/Sales	0.73

More SMA Financials

News

Shares of Symmetry Medical Under Pressure, Down 1.3% - Financial News Network Online - Market Movers

Jun 19, 2013

Symmetry Medical Down 21.2% Since SmarTrend Downtrend Call (SMA) - Comtex Smartrend(R)

Jun 19, 2013

Photo Release -- SMART Transforms Collaboration With New Solutions for Enterprise - Globenewswire

Jun 18, 2013

Relatively Good Performance Detected in Shares of MAKO Surgical in the Health Care Equipment Industry (MAKO, NXTM, BCR, COV, SMA) - Financial News Network Online - News Corner

Jun 17, 2013

Relatively Good Performance Detected in Shares of MAKO Surgical in the Health Care Equipment Industry (MAKO, STJ, THOR, SMA, IDXX) - Financial News Network Online - News Corner

Jun 13, 2013

Short-term Underperformance Detected in Shares of Symmetry Medical in the Health Care Equipment Industry (SMA, MAKO, EW, THOR, OFIX) - Financial News Network Online - News Corner

Jun 12, 2013

Symmetry Medical Shares Down 22.8% Since SmarTrend's Sell Call (SMA) - Comtex Smartrend(R)

Jun 12, 2013

Invacare has the Lowest Price to Sales Ratio in the Health Care Equipment Industry (IVC, NURO, SMA) - Financial News Network Online - News Corner

Jun 11, 2013

See All News Stories on SMA

Broker Recommendations

Current ABR	2.33
ABR (Last Week)	2.33
# of recs in ABR	3
Average Target Price	12.00
Industry Rank by ABR	184 out of 265
Rank in Industry	61 out of 73

More SMA Broker Recommendations

Day Low - High	7.70 - 7.99
52wk Low - High	7.44 - 12.83
Previous Close	7.97
Avg. Volume	424,388
Industry	MED PRODUCTS
Market Cap	297.09 M
Div - Yield	0.00 - 0.00
Beta	1.09
P/E (F1)	21.54
Current Year Est.	0.37
Quarterly Earnings ESP	0.00%

P/E (F1)	21.54
PEG Ratio	2.39
Current Year Est.	0.37
Current Quarter Estimate	0.05
Most Accurate Estimate	0.05
Earnings ESP	0.00%
Next Earnings Report Date	08-08-2013
EPS Last Year	0.47
Expected Earnings Growth	9.00%

Username: Password:

Remember me [?]

Symmetry Medical Inc: (NYSE: SMA)

$7.73

-0.24 (-3.01%)

Volume 318,841

Jun 19 04:02 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description